Practical management of lupus nephritis in pregnancy and the puerperium

References

• Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J. Rheumatol.32(9), 1709–1712 (2005).
   PubMed Web of Science ®Google Scholar
• Tuthill JI, Khamashta MA. Management of antiphospholipid syndrome. J. Autoimmun.33(2), 92–98 (2009).
   PubMed Web of Science ®Google Scholar
• Mackillop LH, Germain SJ, Nelson-Piercy C. Systemic lupus erythematosus. Br. Med. J.335(7626), 933–936 (2007).
   PubMedGoogle Scholar
• Day CJ, Lipkin GW, Savage CO. Lupus nephritis and pregnancy in the 21st century. Nephrol. Dial. Transplant.24(2), 344–347 (2009).
   Web of Science ®Google Scholar
• Williams D, Davison J. Chronic kidney disease in pregnancy. Br. Med. J.336(7637), 211–215 (2008).
   PubMed Web of Science ®Google Scholar
• Cunningham FG, Cox SM, Harstad TW, Mason RA, Pritchard JA. Chronic renal disease and pregnancy outcome. Am. J. Obstet. Gynecol.163(2), 453–459 (1990).
   PubMed Web of Science ®Google Scholar
• Smith MC, Moran P, Ward MK, Davison JM. Assessment of glomerular filtration rate during pregnancy using the MDRD formula. BJOG115(1), 109–112 (2008).
   PubMed Web of Science ®Google Scholar
• Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am. J. Obstet. Gynecol.199(2), 127.e1–6 (2008).
   PubMed Web of Science ®Google Scholar
• Gladman DD, Tandon A, Ibañez D, Urowitz MB. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J. Rheumatol.37(4), 754–758 (2010).
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G, Lima F, Alves J et al. Increased rate of lupus flare during pregnancy and the puerperium; a prospective study of 78 pregnancies. Rheumatology35(2), 133–138 (1996).
   Google Scholar
• Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum.34(12), 1538–1545 (1991).
   PubMed Web of Science ®Google Scholar
• Lockshin MD, Reinitz E, Druzin ML, Murrman M, Estes D. Lupus pregnancy: casecontrol prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am. J. Med.77(5), 893–898, (1984).
   PubMed Web of Science ®Google Scholar
• Moroni G, Quaglini S, Banfi G et al. Pregnancy in lupus nephritis. Am. J. Kidney Dis.40(4), 713–720 (2002).
   PubMed Web of Science ®Google Scholar
• Imbasciati E, Tincani A, Gregorini G et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol. Dial. Transplant.24(2), 519–525 (2009).
   PubMed Web of Science ®Google Scholar
• Wagner SJ, Craici I, Reed D et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus18(4), 342–347 (2009).
   PubMed Web of Science ®Google Scholar
• Huong DL, Wechsler B, Vauthier-Brouzes D, Beaufils H, Lefebvre G, Piette JC. Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann. Rheum. Dis.60(6), 599–604 (2001).
   PubMed Web of Science ®Google Scholar
• Carmona F, Font J, Moga I et al. Class III–IV proliferative lupus nephritis and pregnancy: a study of 42 cases. Am. J. Reprod. Immunol.53(4), 182–188 (2005).
   PubMed Web of Science ®Google Scholar
• Germain S, Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus15(3), 148–155 (2006).
   PubMed Web of Science ®Google Scholar
• Nelson-Piercy C. Renal disease. In: Handbook of Obstetric Medicine (3rd Ed.) Informa Healthcare, London, UK, 180–198 (2006).
   Google Scholar
• Alba P, Bento L, Cuadrado MJ et al. Anti-dsDNA, anti-Sm antibodies and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann. Rheum. Dis.62(6), 556–560 (2003).
   PubMed Web of Science ®Google Scholar
• Patel M, Clarke AM, Bruce IN, Symmons DP. The prevalence and incidence of biopsy-proven lupus nephritis in the UK: evidence of an ethnic gradient. Arthritis Rheum.54(9), 2963–2969 (2006).
   PubMedGoogle Scholar
• Marto N, Bertolaccini ML, Calabuig E, et al. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann. Rheum. Dis.64(3), 444–448 (2005).
   PubMed Web of Science ®Google Scholar
• Cortés-Hernández J, Ordi-Ros J, Labrador M et al. Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am. J. Med.116(3), 165–173 (2004).
   PubMed Web of Science ®Google Scholar
• Karim MY, Yong PF, D’Cruz DP. Clinical importance of autoantibodies in lupus nephritis. Expert Rev. Clin. Immunol.3(6), 937–947 (2007).
   PubMedGoogle Scholar
• Mosca M, Strigini F, Doria A et al. Anti-C1q antibodies in pregnant patients with systemic lupus erythematosus. Clin. Exp. Rheumatol.25(3), 449–452 (2007).
   Google Scholar
• Hayslett JP. The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome. Am. J. Reprod. Immunol.28(3–4), 199–204 (1992).
   PubMedGoogle Scholar
• Tench CM, Isenberg DA. The variation in anti-ENA characteristics between different ethnic populations with systemic lupus erythematosus over a 10-year period. Lupus9(5), 374–376 (2000).
   Google Scholar
• Østensen M, Khamashta M, Lockshin M et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res. Ther.8(3), 209 (2006).
   PubMed Web of Science ®Google Scholar
• Kong NC. Pregnancy of a lupus patient – a challenge to the nephrologist. Nephrol. Dial. Transplant.21(2), 268–272 (2006).
   Google Scholar
• Cooper WO, Hernandez-Diaz S, Arbogast G et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N. Engl. J. Med.354(23), 2443–2451 (2006).
   PubMed Web of Science ®Google Scholar
• von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet355(9198), 87–92 (2000).
   PubMed Web of Science ®Google Scholar
• Ostensen M, Lockshin M, Doria A et al. Update on safety during pregnancy of biological agents and some immunosuppressive antirheumatic drugs. Rheumatology.47(Suppl. 3), iii28–iii31 (2008).
   PubMed Web of Science ®Google Scholar
• Ojeda-Uribe M, Gilliot C, Jung G, et al. Administration of rituximab during the first trimester of pregnancy without consequences for the newborn. J. Perinatol.26(4), 252–255 (2006).
   PubMed Web of Science ®Google Scholar
• Klink DT, van Elburg RM, Schreurs MW, van Well GT. Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. Clin. Dev. Immunol.2008, 271363 (2008).
   PubMedGoogle Scholar
• Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst. Rev.18(2), CD004659 (2007).
   Google Scholar
• Gauer R, Atlas M, Hill J. Clinical inquiries. Does low-dose aspirin reduce preeclampsia and other maternal–fetal complications? J. Fam. Pract.57(1), 54–56 (2008).
   PubMedGoogle Scholar
• Bujold E, Roberge S, Lacasse Y et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet. Gynecol.116(2, Part 1), 402–414 (2010).
   PubMed Web of Science ®Google Scholar
• Le Thi Huong D, Wechsler B, Vauthier-Brouzes D et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the anti/phospholipid syndrome. Rheumatology45(3), 332–338 (2006).
   PubMed Web of Science ®Google Scholar
• Friedman DM, Kim MY, Copel JA et al. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation117(4), 485–493 (2008).
   PubMed Web of Science ®Google Scholar
• Cote AM, Brown MA, Lam E et al. Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review. Br. Med. J.336(7651), 1003–1006 (2008).
   PubMed Web of Science ®Google Scholar
• SalesiM, Karimifar M, Farajzadegan Z et al. The protein–creatinine ratio in spot morning urine samples and 24-h urinary protein excretion in patients with systemic lupus erythematosus. Rheumatol. Int.29(5), 503–507 (2009).
   Google Scholar
• Hebert LA, Birmingham DJ, Shidham G, et al. Random spot urine protein/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patients. Nephron. Clin. Pract.113(3), c177–c182 (2009).
   Google Scholar
• Buhimschi CS, Magloire L, Funai E et al. Fractional excretion of angiogenic factors in women with severe preeclampsia. Obstet. Gynecol.107(5), 1103–1113 (2006).
   PubMedGoogle Scholar
• Sunderji S, Gaziano E, Wothe D et al. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study. Am. J. Obstet. Gynecol.202(1), 40.e1–7 (2010).
   Web of Science ®Google Scholar